(Bloomberg) -- The following is a list of companies
whose shares may have unusual price changes on U.S. exchanges
tomorrow. This preview includes news that broke after exchanges
closed two days ago. Stock symbols are in parentheses after
company names. Shares prices are as of 7:30 a.m. New York time.
Actelion Ltd. (ALIOF US) shares rose $1.44, or 3.1 percent,
to $47.89 in regular trading in Germany. A newly approved rival
to its best-selling Tracleer lung treatment may not be as big a
threat as previously thought, some analysts said. Gilead Sciences
Inc. (GILD US) on June 15 won U.S. approval for ambrisentan,
which will compete with Tracleer as a treatment for pulmonary
arterial hypertension, a narrowing of the arteries that causes
shortness of breath and heart failure.
Read more at Bloomberg Stocks News
whose shares may have unusual price changes on U.S. exchanges
tomorrow. This preview includes news that broke after exchanges
closed two days ago. Stock symbols are in parentheses after
company names. Shares prices are as of 7:30 a.m. New York time.
Actelion Ltd. (ALIOF US) shares rose $1.44, or 3.1 percent,
to $47.89 in regular trading in Germany. A newly approved rival
to its best-selling Tracleer lung treatment may not be as big a
threat as previously thought, some analysts said. Gilead Sciences
Inc. (GILD US) on June 15 won U.S. approval for ambrisentan,
which will compete with Tracleer as a treatment for pulmonary
arterial hypertension, a narrowing of the arteries that causes
shortness of breath and heart failure.
Read more at Bloomberg Stocks News
No comments:
Post a Comment